Provided by Tiger Trade Technology Pte. Ltd.

Fulcrum Therapeutics

3.83
-0.0050-0.13%
Volume:486.69K
Turnover:1.86M
Market Cap:291.84M
PE:-3.16
High:3.86
Open:3.84
Low:3.78
Close:3.83
52wk High:15.74
52wk Low:2.83
Shares:76.30M
Float Shares:63.49M
Volume Ratio:0.19
T/O Rate:0.77%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.2104
EPS(LYR):-1.1819
ROE:-32.38%
ROA:-19.59%
PB:0.94
PE(LYR):-3.24

Loading ...

Jul 29, 2025

Major Issues Report

Form 8-K - Current report
Jun 27, 2025

Major Issues Report

Form 8-K - Current report
May 01, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 01, 2025

Major Issues Report

Form 8-K - Current report
Mar 05, 2025

Major Issues Report

Form 8-K - Current report
Feb 25, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 25, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 25, 2025

Major Issues Report

Form 8-K - Current report
Jan 13, 2025

Major Issues Report

Form 8-K - Current report
Dec 24, 2024

Major Issues Report

Form 8-K - Current report
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 13, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 13, 2024

Major Issues Report

Form 8-K - Current report
Nov 12, 2024

Major Issues Report

Form 8-K - Current report
Sep 25, 2024

Major Issues Report

Form 8-K - Current report
Sep 20, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Sep 16, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Sep 12, 2024

Major Issues Report

Form 8-K - Current report
Aug 23, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]